Actively Recruiting

All Genders
Healthy Volunteers
ID06016946

Friedreich Ataxia Global Clinical Consortium UNIFIED Natural History Study

Led by Friedreich's Ataxia Research Alliance · Updated on 2025-06-17

3000

Participants Needed

34

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are conducting a global, multicenter, prospective, longitudinal, observational natural history study to better understand Friedreich ataxia, a rare inherited neurological and cardiac condition caused by mutations in the FXN gene. This study aims to support the development of safe and effective drugs and biological treatments by tracking the disease progression in diagnosed individuals worldwide over time. Participants will be assessed annually for up to 25 years through yearly study visits. Data collection includes medical records, neurological exams, timed walking tests, upper limb function measures, and patient-reported quality of life assessments. Additional optional assessments at some sites may cover speech, vision, fatigue, balance, and cognition. This study combines previous natural history studies to strengthen data and expand research networks globally. During the study, participants will undergo evaluations such as neurological and functional assessments, cardiac examinations, laboratory tests, and health questionnaires. Researchers will monitor changes in clinical outcomes like disease progression, symptom severity, and quality of life using measures including the modified Friedreich Ataxia Rating Scale and the Scale for the Assessment and Rating of Ataxia. This long-term observation aims to identify disease milestones, track treatment impacts, and inform future clinical trials and outcome measures.

CONDITIONS

Brief Title

Friedreich Ataxia Global Clinical Consortium UNIFIED Natural History Study

Who Can Participate

All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Both males and females of any age
  • Genetically confirmed diagnosis of Friedreich ataxia
  • Written informed consent provided by participant or legally authorized representative
  • For minors, assent from the child and consent from parent or guardian must be obtained
Not Eligible

You will not qualify if you...

  • Unable or unwilling to provide informed consent
  • Acute or ongoing medical or other conditions interfering with study participation
  • Unlikely or unable to comply with study protocol requirements as judged by the investigator

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Long-term Monitoring

Duration - Up to 25 years

Participants attend yearly study visits where data on disease progression, symptoms, and quality of life are collected through neurological exams, functional assessments, and questionnaires.

Annual visits

Trial Site Locations

Total: 34 locations

1

UCLA Ataxia Center

Los Angeles, California, United States, 90095

Actively Recruiting

2

University of Colorado

Denver, Colorado, United States, 80045

Actively Recruiting

3

University of Florida - Neurology

Gainesville, Florida, United States, 32610

Actively Recruiting

4

USF Ataxia Research Center

Tampa, Florida, United States, 33612

Actively Recruiting

5

Emory University Hospital - Neurology

Atlanta, Georgia, United States, 30329

Actively Recruiting

6

University of Iowa, Stead Family Children's Hospital

Iowa City, Iowa, United States, 52242

Actively Recruiting

7

Ohio State University - Neurology

Columbus, Ohio, United States, 43221

Actively Recruiting

8

Children's Hospital of Philadelphia

Philadelphia, Pennsylvania, United States, 19104

Actively Recruiting

9

St. Jude Children's Research Hospital

Memphis, Tennessee, United States, 38105

Actively Recruiting

10

Murdoch Childrens Research Institute

Parkville, Victoria, Australia, 3052

Actively Recruiting

11

Medical University Innsbruck, Department of Neurology

Innsbruck, Austria, 6020

Actively Recruiting

12

Université Libre de Bruxelles, Hôpital Erasme, Dpt of Neurology

Brussels, Belgium, 1070

Actively Recruiting

13

University of Campinas

Campinas, Brazil

Not Yet Recruiting

14

The Hospital for Sick Children

Toronto, Ontario, Canada, M5G 1X8

Actively Recruiting

15

CHUM - Hopital Notre-Dame

Montreal, Quebec, Canada, h2x0a9

Actively Recruiting

16

McGill University Health Centre - Montreal Neurological Institute

Montreal, Quebec, Canada, H9R 2Y2

Actively Recruiting

17

Motol University Hospital, Centre for Hereditary Ataxias

Prague, Czechia, 150 06

Actively Recruiting

18

Paris Brain Institute

Paris, France, 75013

Actively Recruiting

19

Hôpital de Hautepierre, Service de Neurologie

Strasbourg, France, 67098

Not Yet Recruiting

20

University Hospital Aachen, Dept. of Neurology

Aachen, Germany, 52074

Actively Recruiting

21

Deutsches Zentrum Für Neurodegenerative Erkrankungen

Bonn, Germany, 53105

Not Yet Recruiting

22

University of Munich, Dept. of Neurology, Friedrich-Baur-Institut

Munich, Germany, 80336

Actively Recruiting

23

University of Tübingen, Dept. of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research

Tübingen, Germany, 72076

Actively Recruiting

24

National and Kapodistrian University of Athens, Neurogenetics Unit

Athens, Greece, 11528

Actively Recruiting

25

All India Institute of Medical Sciences (AIIMS)

New Delhi, National Capital Territory of Delhi, India, 110020

Actively Recruiting

26

Tallaght University Hospital, Department of Neurology

Dublin, Ireland, D24 TP66

Actively Recruiting

27

Referente Clinico-Scientifico di Polo IRCCS "E. Medea"

Conegliano, Italy, 21015

Actively Recruiting

28

Fondazione IRCCS Istituto Neurologico Carlo Besta

Milan, Italy, 20133

Actively Recruiting

29

Bambino Gesù Children's Hospital, Department of Neurosciences

Roma, Italy, 00146

Not Yet Recruiting

30

Stichting Radboud Universitair Medisch Centrum

Nijmegen, Netherlands, 6525

Actively Recruiting

31

Auckland City Hospital

Auckland, New Zealand, 1023

Actively Recruiting

32

Hospital Sant Joan de Déu, Servicio de Neurología

Barcelona, Spain, 08950

Not Yet Recruiting

33

Hospital Universitario La Paz, Servicio de Neurologia

Madrid, Spain, 28046

Not Yet Recruiting

34

University College of London, Ataxia Centre, National Hospital for Neurology and Neurosurgery

London, United Kingdom, WC1N 3 BG

Not Yet Recruiting

Loading map...

Research Team

C

Cait Monette

J

Jennifer Farmer

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

A Phase 1/2, Open-Label, Multiple Ascending Dose Study to As...

Friedreich Ataxia

Actively Recruiting

3 locations

A Post-marketing Observational Study to Assess Pregnancy and...

Friedreich Ataxia

Actively Recruiting

1 location

A Phase 3 Study to Evaluate the Efficacy, Safety, Pharmacoki...

Friedreich Ataxia

Actively Recruiting

34 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here